Performance of a novel fluorogenic probe assay for the detection of extended-spectrum-β-lactamase or plasmid AmpC β-lactamase–producing Enterobacterales directly from simulated blood culture bottles
Authors:
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 175, 105988
Abstract
No abstract availableKeywords
Funding Information
- Korea Health Industry Development Institute (HI16C0443)
This publication has 13 references indexed in Scilit:
- Performance of a novel fluorogenic chimeric analog for the detection of third-generation cephalosporin resistant bacteriaJournal of Microbiological Methods, 2016
- Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical featuresEuropean Journal of Clinical Microbiology & Infectious Diseases, 2016
- Evaluation of the Nanosphere Verigene BC-GN Assay for Direct Identification of Gram-Negative Bacilli and Antibiotic Resistance Markers from Positive Blood Cultures and Potential Impact for More-Rapid Antibiotic InterventionsJournal of Clinical Microbiology, 2014
- Rapid detection of carbapenemase-producing Enterobacteriaceae from blood culturesClinical Microbiology and Infection, 2014
- Early diagnosis of resistant pathogensVirulence, 2013
- Rapid Detection of Extended-Spectrum-β-Lactamase-Producing EnterobacteriaceaeJournal of Clinical Microbiology, 2012
- Characteristics of Microorganisms Isolated from Blood Cultures at Nine University Hospitals in Korea during 2009Korean Journal of Clinical Microbiology, 2011
- Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2006
- Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC-Type-β-Lactamase-Producing Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2004
- Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicineClinical Chemistry, 1993